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BRIEF DEFINITIVE REPORT
        NF-    B is a ubiquitous transcription factor that 
regulates expression of proinfl  ammatory  and 
antiapoptotic genes and is thought to play an im-
portant role in driving the infl  ammatory response 
(  1  ). NF-    B activation in response to proin-
fl  ammatory stimuli is regulated by I    B kinase 
(IKK)    , which has recently become a major tar-
get for the development of new antiinfl  amma-
tory drugs (  2  ). However, we have previously 
established both pro- and antiinfl  ammatory roles 
for NF-    B in infl  ammation (  3, 4  ). In this study, 
we have tested the hypothesis that NF-    B has 
tissue-specifi  c roles in infl  ammation; although 
NF-    B activation in epithelial cells is required 
to drive the infl  ammatory response, NF-    B ac-
tivity in macrophages has an opposing role in 
the resolution of infl  ammation. 
  Macrophages are an extremely heterogeneous 
lineage displaying a range of both pro- and 
  antiinfl  ammatory functions (  5, 6  ). Two extremes 
in the spectrum of macrophage function are 
represented by the   “  classically  ”   activated (or 
M1) and the alternative (or M2) phenotypes (  7  ). 
The M1 phenotype is typifi  ed by IFN-     –  primed 
macrophages and is characterized by increased 
MHC class II, IL-12, and inducible nitric oxide 
synthase (NOS2) expression. M2 macrophages 
are characterized by decreased expression of 
NOS2, MHC class II, and IL-12, but ele-
vated expression of antiinfl  ammatory cytokines 
such as IL-10. The M2 phenotype is promoted 
by Th2 cytokines such as IL-4 and IL-13. 
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  The nuclear factor     B (NF-    B) pathway plays a central role in infl  ammation and immunity. 
In response to proinfl  ammatory cytokines and pathogen-associated molecular patterns, NF-
    B activation is controlled by I    B kinase (IKK)    . Using Cre/  lox  -mediated gene targeting of 
IKK    , we have uncovered a tissue-specifi  c role for IKK     during infection with group B 
streptococcus. Although deletion of IKK     in airway epithelial cells had the predicted effect 
of inhibiting infl  ammation and reducing innate immunity, deletion of IKK     in the myeloid 
lineage unexpectedly conferred resistance to infection that was associated with increased 
expression of interleukin (IL)-12, inducible nitric oxide synthase (NOS2), and major histo-
compatibility complex (MHC) class II by macrophages. We also describe a previously un-
known role for IKK     in the inhibition of signal transducer and activator of transcription 
(Stat)1 signaling in macrophages, which is critical for IL-12, NOS2, and MHC class II 
expression. These studies suggest that IKK     inhibits the   “  classically  ”   activated or M1 
macrophage phenotype during infection through negative cross talk with the Stat1 path-
way. This may represent a mechanism to prevent the over-exuberant activation of macro-
phages during infection and contribute to the resolution of infl  ammation. This establishes a 
new role for IKK     in the regulation of macrophage activation with important implications 
in chronic infl  ammatory disease, infection, and cancer. 1270 IKK  β   INHIBITS   “  CLASSICAL  ”   MACROPHAGE ACTIVATION | Fong et al.
mine if the increased infl   ammatory response could confer 
resistance to infection. IKK          Mye   mice were indeed more 
resistant to systemic infection with GBS. More than 60% of 
IKK          Mye   mice survived a lethal dose of GBS beyond 48 h, 
whereas   >  90% of littermate controls had died within 24 h, 
and none survived to 48 h (  Fig. 2 A  ).   Furthermore, resistance 
of IKK          Mye   mice to lethal GBS infection correlated with 
signifi  cantly lower titres of bacteria in the blood (  Fig. 2 B  ; 
IKK      f/f   vs. IKK          Mye  ; **, P = 0.0057). To investigate the 
mechanism for this resistance, we measured the expression 
of proinfl   ammatory cytokines in the spleen and serum of 
GBS-infected mice.   Fig. 2 C   shows a signifi  cant increase in 
Generally, M2 macrophages are considered antiinfl  ammatory 
cells, whereas M1 macrophages are proinfl  ammatory. The sig-
naling pathways that regulate these phenotypes in vivo are 
not well understood. 
  We used Cre/  lox  -mediated gene targeting of IKK     in 
lung epithelial cells and macrophages (  9, 10  ) and show that 
IKK     deletion in airway epithelial cells inhibits infl  ammation 
and prevents clearance of bacteria in the lung. However, 
IKK     deletion in macrophages has the opposite role, increas-
ing the infl  ammatory response and enhancing the clearance 
of bacteria. In addition, we show that IKK     activation sup-
presses the classically activated or M1 macrophage pheno-
type, and we present evidence for negative regulation of 
Stat1 activation by IKK    . These fi  ndings represent impor-
tant new information regarding the role of NF-    B in macro-
phage biology during infl  ammation and infection. Furthermore, 
cross talk between IKK     and Stat1 signaling pathways could 
have implications for the development and clinical use of 
IKK     inhibitors. 
    RESULTS AND DISCUSSION   
  To investigate the tissue-specifi  c role of IKK     in innate im-
munity, we specifi  cally targeted the   Ikk       gene using Cre/  lox  -
mediated recombination in lung epithelial cells and myeloid 
cells using the clara cell  –  specifi  c protein promoter (Cc10) 
and lysozyme promoter to express Cre in bronchial airway 
epithelial cells and the myeloid cell lineage, respectively. Cre 
transgenic mice were crossed to   Ikk      f/f     mice to generate tis-
sue-specifi  c deletion of   Ikk      . Tissue-specifi  c targeting of the 
  Ikk       gene in these mice has been established (  9, 10  ). To study 
innate immunity, we infected IKK          Mye   (myeloid deletion) 
and IKK          Epi   (epithelial deletion) mice intranasally with 
group B streptococcus (GBS) and measured bacterial clear-
ance from the lung (  11  ).   Fig. 1   A shows that IKK          Epi   mice 
had impaired ability to clear the GBS infection, demonstrat-
ing signifi  cantly higher bacterial titres in the lung than litter-
mate controls (  Fig. 1 A  ; IKK      f/f-Otet-cre   vs. IKK          Epi  ; *, P = 
0.0242).   Histological analysis of lung tissue from IKK          Epi   
mice infected with GBS revealed reduced neutrophil (PMN) 
recruitment and persistence of bacteria in the lung (  Fig. 1 B  ). 
In contrast, IKK          Mye   mice showed enhanced clearance of 
bacteria (  Fig. 1 C  ; IKK      f/f   vs. IKK          Mye  ; *, P = 0.0304), and 
analysis of lung tissue from IKK          Mye   mice revealed increased 
PMN infi  ltration after 4 h (  Fig. 1, D and E  ). Furthermore, 
infl  ammation in GBS-infected control mice completely resolved 
after 24 h; however, in IKK          Mye   mice infl  ammation failed 
to resolve despite increased clearance of bacteria (  Fig. 1 D  ). 
These experiments suggested that IKK     played a tissue-specifi  c 
role in response to infection and that IKK     activity in air-
way epithelium was required for leukocyte recruitment and 
clearance of bacteria; however, IKK     activation in resident 
macrophages or myeloid cells recruited to the lung inhibited 
the infl  ammatory response and therefore impaired clearance 
of bacteria. 
  We next systemically challenged IKK          Mye   mice with a 
lethal dose of GBS and monitored their survival to deter-
    Figure 1.         Tissue-specifi  c role for IKK     in Streptococcal pneumonia.   
(A) IKK       Epi   and  IKK   f/f-Otet-cre   control mice were infected intranasally 
with 5   ×   10  6   CFUs GBS in PBS. Bronchialveolar lavage was performed 
after 4 h, and CFUs were determined by serial dilution on Todd-Hewitt 
agar plates (  n   = 11  –  14; *, P = 0.0242). (B) Hematoxylin and eosin stain 
(left, H+E) of lungs from GBS-infected mice after 4 h showed reduced 
leukocyte infi  ltration in IKK       Epi   mice (arrows). Gram stain (right) of in-
fected lungs showed accumulation of bacteria in alveolar spaces of 
IKK       Epi   lungs (arrows). Representative panels are shown from   n   = 8. Bar, 
100   μ  m. (C) IKK       Mye   and  IKK   f/f   control mice were infected as described 
above, and BAL CFUs were measured at 4 h (  n   = 11  –  14; *, P = 0.0304). 
(D) Hematoxylin and eosin stain of lungs from GBS-infected mice after 4 
and 24 h showed resolution of peribronchial infl  ammation in the lungs of 
IKK    f/f   mice at 24 h (top, arrows); however, infl  ammation in IKK       Mye  
mice fails to resolve (bottom, arrows). Bar, 200   μ  m. (E) PMN recruitment 
in IKK       Mye   and  IKK   f/f   mice infected with GBS was counted under high 
power fi  eld after hematoxylin and eosin stain. Data are represented as 
mean   ±   SEM of   n   = 8 (**, P = 0.005).     JEM VOL. 205, June 9, 2008  1271
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In fact, IL-1     levels were slightly decreased, although these 
data did not reach statistical signifi  cance (  Fig. 2 C  ). To fur-
ther analyze the macrophage phenotype in IKK          Mye   mice, 
we isolated peritoneal macrophages from GBS-infected mice 
and measured MHC class II expression by FACS. IKK          Mye   
mice showed a threefold increase in MHC class II expression 
compared with control mice (  Fig. 2 D  ). Expression of the 
costimulatory molecules CD80 (B7.1) and CD86 (B7.2) were 
also increased on macrophages from IKK          Mye   mice, whereas 
CD124 (IL-4R    ) expression was decreased (Fig. S1 A, 
available at http://www.jem.org/cgi/content/full/jem
.20080124/DC1). We also analyzed IL-12p40 and arginase-1 
mRNA expression in the spleen from GBS-infected mice; 
although expression of IL-12p40 was increased in IKK          Mye   
mice, expression of the antiinfl  ammatory macrophage marker 
arginase-1 was reciprocally decreased (  Fig. 2 E  ). In addition, 
immunohistochemical analysis of lungs from GBS-infected 
mice revealed dramatically increased NOS2 expression in 
alveolar macrophages, whereas NOS2 expression in lung 
epithelium remained unchanged (  Fig. 2 F  ). IL-12 is a crit-
ical cytokine for host defense (  12  ) and, along with MHC 
class II and NOS2, is a marker for classically activated or M1 
macrophages (  7  ). On the other hand, increased expression 
of arginase-1 and IL-10 is characteristic of alternative M2 
macrophage activation, which is dependent on CD124 ex-
pression (  7  ). 
  Previous work from our group and others has demon-
strated that IKK     and NF-    B activation in bronchial epithe-
lium is required for leukocyte recruitment and infl  ammation 
in the lung by regulating the expression of chemotactic cyto-
kines (  9, 13  ). The impaired ability of IKK          Epi   mice to clear 
bacteria is therefore quite expected; however, the fi  nding 
that IKK     deletion in myeloid cells increases infl  ammation 
and bacterial clearance was somewhat surprising. In IKK         Mye   
mice, IKK     expression is eff  ectively deleted in both macro-
phages and PMNs (  14  ). PMNs are the major defense against 
extracellular bacteria such as GBS, although macrophage ac-
tivation is also critical to PMN recruitment in infl  ammation 
(  15  ). Previous work from our group has also shown that NF-
    B can have a proapoptotic role in leukocytes during the res-
olution of infl  ammation (  3  ), which was recently confi  rmed 
in IKK          Mye   mice (  4  ); however, we found no diff  erence in 
apoptosis in the lungs of GBS-infected IKK          Mye   mice (not 
depicted). We performed in vitro killing assays with macro-
phages and PMNs isolated from IKK          Mye   mice to test their 
direct antimicrobial activity. Although IKK            macrophages 
showed some level of increased killing in vitro, IKK            PMNs 
did not (  Fig. 3, A and B  ).   This suggested increased phagocytic 
killing by macrophages, probably through increased NOS2 
expression, and macrophage-mediated PMN recruitment was 
responsible for enhanced clearance of bacteria rather than 
increased PMN activation. To test this hypothesis, we chal-
lenged IKK          Mye   mice intranasally with a noninfectious 
stimulus, bacterial LPS, to measure activation of alveolar 
macrophages and PMN recruitment. Lung tissue was col-
lected for FACS analysis of PMN recruitment (CD11b  +   
the levels of protective Th1 cytokines IFN-     and IL-12 in 
IKK          Mye   mice (  Fig. 2 C  ; IKK      f/f   vs. IKK          Mye  ; IFN-    : *, 
P = 0.0148; IL-12: **, P = 0.0023). Recently it has been re-
ported that IKK     inhibits caspase 1  –  dependent IL-1     release 
in LPS-stimulated PMNs (  4  ); however, we found no increase 
in serum IL-1     in GBS-infected IKK          Mye   mice (  Fig. 2 C  ). 
    Figure 2.         IKK     inhibits M1 macrophage activation during infec-
tion.   (A) IKK       Mye   and  IKK   f/f   control mice were infected by intraperito-
neal injection of 5   ×   10  7   CFUs GBS in PBS, and survival was monitored (  n   = 
16  –  17). (B) Blood was collected at 4 h by retroorbital bleed. Serial dilu-
tions of blood samples were plated in triplicate on Todd-Hewitt agar 
plates, and CFUs were counted (  n   = 9  –  10; **, P = 0.0057). (C) Serum levels 
of IL-12p70, IL-1    , and spleen IFN-     were measured by ELISA (  n   =  7 – 8; 
IL-12p70: **, P = 0.0023; IFN-    : *, P = 0.0148). (D) Total RNA was isolated 
from the spleens of GBS-infected mice for real-time PCR analysis of IL-
12p40 and arginase-1 expression. Data are represented as fold induction 
of mRNA expression compared with uninfected mice (  n   =  7 – 8).  (E)  MHC 
class II expression on peritoneal macrophages measured by FACS (per-
centage of positive cells indicated). (F) Immunohistochemical analysis of 
NOS2 expression in GBS-infected lungs shows increased expression of 
NOS2 in alveolar macrophages of IKK       Mye   mice (arrows), whereas ex-
pression in bronchial epithelial cells remains unchanged (asterisks). Rep-
resentative panels are shown from   n   =  8.  Bar,  200   μ m.   1272 IKK  β   INHIBITS   “  CLASSICAL  ”   MACROPHAGE ACTIVATION | Fong et al.
Immunohistochemical analysis of LPS-stimulated lungs from 
IKK          Mye   mice also revealed increased NOS2 expression in 
alveolar macrophages (  Fig. 3 F  ). In addition, cytokine analysis 
of bronchialveolar lavage fl  uid (BAL) from LPS-challenged 
mice showed increased IL-12 production but reduced levels 
of the antiinfl  ammatory cytokine IL-10 in IKK          Mye   mice 
(  Fig. 3 E  ; IKK      f/f   vs. IKK          Mye  ; IL-12: *, P = 0.0318), in 
keeping with an increase in M1 macrophage activation. 
  We further analyzed the phenotype of IKK            macro-
phages after stimulation in vitro. Both resident and elicited 
peritoneal macrophages from IKK          Mye   mice express nor-
mal levels of typical macrophage lineage markers (including 
CD11b, F4/80, and CD68) and display no distinctive mor-
phology (not depicted). Peritoneal macrophages were elic-
ited and stimulated in vitro with heat-killed bacteria over a 
24-h time course, and protein extracts were prepared for bio-
chemical analysis. As expected, there was a profound im-
pairment in IKK activity and NF-    B activation in IKK            
macrophages, whereas activation of JNK MAPK remained 
unchanged (  Fig. 4 A  ).   However, although the absence of 
IKK activity was associated with decreased expression of pro  –
  IL-1     and TNF-    , expression of NOS2 was in fact elevated, 
which correlated with increased tyrosine phosphorylation of 
Stat1 (pY-Stat1) (  Fig. 4, B  –  D  ). Expression of the endogenous 
inhibitor of Stat1, suppressor of cytokine signaling (SOCS)1 
(  16  ), was unaltered in IKK            macrophages (  Fig. 4 B  ). Stat1 
is a critical transcription factor for NOS2, IL-12, and MHC 
class II expression (  17  ). These data suggest that IKK     activity 
in macrophages suppresses NOS2 as well as MHC class II and 
IL-12 expression during infection by antagonizing Stat1. M1 
macrophage activation is typifi  ed by IFN-     priming (  7  ), and 
IFN signaling in macrophages absolutely requires Stat1 (  17  ). 
In macrophages stimulated in vitro with Toll-like receptor 
ligands, Stat1 is activated by the autocrine production of 
IFN-    ; however, GBS-induced IFN-     expression was in-
hibited in IKK            macrophages (  Fig. 4 D  ). To investigate 
a role of IKK     in the cross regulation of Stat1 signaling, we 
stimulated IKK            macrophages with bacterial LPS and re-
combinant IFN-     in vitro. As shown in   Fig. 5 A  , IKK            
macrophages had increased activation of Stat1 and NOS2 ex-
pression when stimulated with LPS/IFN-    , whereas activa-
tion of Stat3 appeared unchanged.   IFN-     and Stat1 strongly 
activate MHC class II expression in macrophages. To con-
fi  rm the in vivo data described above, we measured MHC 
class II expression on macrophages stimulated in vitro with 
IFN-    . MHC class II expression was dramatically enhanced 
with IKK            macrophages (  Fig. 5 B  ). In addition, IKK            
macrophages showed an increased ability to drive T cell pro-
liferation in an allogenic mixed lymphocyte assay (Fig. S1 B). 
In further experiments, we used a recombinant adenovirus 
to express a dominant-negative inhibitor of IKK     (IKK      dn  ) 
in macrophages in vitro (  18  ).   Fig. 5 C   shows that expression 
of IKK      dn   increased both Stat1 activation and NOS2 ex-
pression upon stimulation with LPS. Similar results were 
obtained with heat-killed bacteria (not depicted). Expression 
of IKK      dn   also dramatically increased LPS/IFN-      –  induced 
Gr-1  +   staining), and macrophage activation was measured by 
MHC class II expression (CD11b  +   Gr-1        MHC class II  +  ). 
  Fig. 3 C   shows increased MHC class II expression on alveolar 
macrophages from IKK          Mye   mice compared with control 
mice. FACS analysis of lung cells also revealed increased 
PMN recruitment in LPS-challenged IKK          Mye   mice (  Fig. 3 D  ). 
    Figure 3.         IKK     inhibits M1 macrophage activation in response to 
LPS in vivo.   (A) Peritoneal macrophages (PM) and (B) neutrophils (PMN) 
were isolated from IKK       Mye   and  IKK   f/f   mice for in vitro killing assays 
with GBS (MOI of 5:1). (C) IKK       Mye   and IKK    f/f   mice were challenged 
intranasally with 10 ng LPS in PBS. After 4 h, lungs were harvested and 
digested for FACS analysis of CD11b (myeloid), Gr-1 (PMN), and MHC class 
II expression. A representative histogram of MHC class II expression on 
CD11b  +   Gr-1       alveolar macrophages is shown. (D) Tabulated data of mean 
fl  uorescence intensity for CD11b  +   Gr-1       MHC class II  +  – activated  macro-
phages in the lung and PMN recruitment as percentage of BAL cells from 
LPS-challenged mice (data are represented as mean   ±   SEM of   n   =  6). 
(E) In parallel experiments, IL-12 and IL-10 levels were measured in lung 
homogenates from LPS-challenged mice by ELISA. Data are represented as 
mean   ±   SEM (  n   = 8; *, P = 0.0381). (F) Immunohistochemical analysis of 
NOS2 expression in LPS-challenged mice. IKK       Mye   mice show increased 
expression of NOS2 in alveolar macrophages compared with IKK    f/f   con-
trol mice (arrows). Representative panels are shown from   n   = 6 mice. 
Bar,  100   μ m.   JEM VOL. 205, June 9, 2008  1273
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  We previously described a role for IKK    , the sister kinase 
of IKK    , in limiting infl  ammation during infection and resis-
tance to septic shock, by regulating the magnitude and dura-
tion of NF-    B activation (  13  ). In the current study, we 
describe a specifi  c role for IKK     in limiting the expression of 
Stat-1  –  regulated genes. There is clearly still much to learn 
about the relative and specifi  c roles for IKK     and IKK     in 
infl  ammation and immunity. Our working hypotheses, based 
on previously published work and data presented here, is that 
IL-12 production (  Fig. 5 D  ). To confi  rm the role of IKK     in 
the suppression of Stat1 transcriptional activity, we performed 
reporter assays in RAW 264.7 macrophages using a GAS lu-
ciferase reporter gene. Transient overexpression of IKK     in 
RAW cells inhibited GAS reporter activity, whereas trans-
fection of the endogenous NF-    B inhibitor I    B     increased 
GAS reporter activation (  Fig. 5 E  ). As a positive control, over-
expression of SOCS1 inhibited GAS activity. Interestingly, 
previous studies have also described sustained IL-12 expression 
in macrophages defi  cient in p50 and heterozygous for RelA 
expression (  19  ), suggesting that NF-    B activation down-
stream of IKK     suppresses IL-12 expression. However, these 
studies did not include analysis of Stat1 activation. Our data 
would suggest that IL-12 expression is inhibited in macro-
phages by the NF-    B  –  dependent expression of a Stat1 inhibi-
tor other than SOCS1. 
    Figure 4.         IKK     inhibits Stat-1 activation in GBS-infected macro-
phages.   (A) Peritoneal macrophages from IKK       Mye   and  IKK   f/f   mice  were 
stimulated in vitro with heat-killed GBS (MOI of 20:1). Protein extracts 
were prepared at the indicated time points for biochemical analysis. IKK 
and JNK activity was measured by IP kinase assay (KA) using recombinant 
substrates GST-I   B   1-54   or  GST-cJun 1-79  , respectively. NF-   B  activation 
was measured by electrophoretic mobility shift assay (EMSA) using   32 P-
labeled     B consensus oligonucleotide. (B) Expression of IKK, pro  –  IL-1   , 
NOS2, tyrosine 701 phosphorylation of Stat1 (pY-Stat1), serine 726 
phosphorylation of Stat1 (pS-Stat1), total Stat1, and SOCS1 was mea-
sured by immunoblot analysis of cell lysates using actin as a loading con-
trol. (C) In parallel experiments, TNF-     production in cell culture 
supernatants was measured by ELISA, and (D) total RNA was isolated for 
real-time PCR analysis of TNF-     (Tnfa) and IFN-     (Ifnb) mRNA expression. 
Data are represented as mean   ±   SEM of   n   = 4. Representative data are 
shown from at least three independent experiments.     
    Figure 5.         IKK     inhibits IFN-     signaling in macrophages.   (A)  Perito-
neal macrophages from IKK       Mye   and  IKK   f/f   mice were stimulated 
in vitro with 100 ng/ml LPS in combination with 100 U/ml recombinant 
mouse IFN-    , and protein extracts were prepared at the indicated time 
points. NOS2 expression, pY-Stat1, and pY-Stat3 were measured by im-
munoblot analysis. (B) Peritoneal macrophages from IKK       Mye   and  IKK   f/f  
mice were stimulated in vitro, with IFN-     and MHC class II expression 
analyzed by FACS. Representative data are shown from at least three 
independent experiments. (C) BMDMs were infected with recombinant 
adenovirus expressing a dominant-negative inhibitor of IKK     (Ad-IKK   dn ) 
or EGFP (Ad-GFP) 48 h before stimulation with LPS. NOS2 and pY-Stat1 
expression was measured by immunoblot analysis at the indicated time 
points. (D) BMDMs were infected with Ad-IKK    dn   or Ad-GFP before stimu-
lation with LPS/IFN-    , and IL-12p40 production was measured in cell 
culture supernatants by ELISA. Data are represented as mean   ±   SEM of 
  n   = 4. (E) RAW 264.7 macrophages were transfected with GAS luciferase 
reporter and either empty vector (pCDNA) or cDNA expressing IKK   ,  I  B  , 
or SOCS1. After LPS/IFN-     stimulation for 6 h, GAS reporter activity was 
measured by dual luciferase activity assay. Data are represented as rela-
tive light units (RLU) normalized for transfection effi  ciency with pRLTK.     1274 IKK  β   INHIBITS   “  CLASSICAL  ”   MACROPHAGE ACTIVATION | Fong et al.
activation of this pathway is a major determinant of the M1 
macrophage phenotype. Collectively, these data suggest that 
IKK     activation plays an important role in suppression of this 
phenotype, contributing to both the resolution of infl  amma-
tion during infection and the suppression of macrophage tu-
moricidal activity in cancer. The potential to manipulate the 
infl  ammatory phenotype of macrophages by targeting IKK     
may off  er therapeutic opportunities for the treatment of in-
fl  ammatory diseases, infection, and cancer. 
  MATERIALS AND METHODS 
  Mice.     The generation and characterization of IKK      f/f  , IKK          Mye  , IKK      f/f-
Otet-cre  , and IKK          Epi   mice has been described (  9, 10  ). IKK      f/f   littermate 
control mice on a C57Bl6/J genetic background were used for experiments 
with IKK      f/f-LysM-cre   (IKK          Mye  ) mice, and IKK      f/f-Otet-cre   littermate controls 
were used in experiments with IKK      f/f-Otet-cre-CC10-rtta   (IKK          Epi  ) mice. Ani-
mal husbandry and procedures were performed in accordance with Queen 
Mary University of London UK Home Offi   ce guidelines. 
  Infections.     The clinical GBS isolate, NCTC10/84 (serotype V), was grown 
in Todd-Hewitt Broth (Difco) without agitation at 37  °  C to an OD  600   of 0.4, 
equivalent to 10  8   CFUs/ml. Bacteria collected by centrifugation were 
washed with sterile PBS. Mice were inoculated intranasally with 3   ×   10  7   
CFUs NCTC in 30   μ  l PBS (  11  ). Cn strain 52 was obtained from the Ameri-
can Type Culture Collection and grown to stationary phase (48  –  72 h) at 
room temperature in Sabouraud dextrose broth (Difco). The cultures were 
washed in saline, counted on a hemocytometer, and diluted in sterile PBS. 
Stock concentrations and viability were confi  rmed by plating on Sabouraud 
agar plates and incubation for 48 h at room temperature before colony 
counts. Mice were inoculated intranasally with 10  5   CFUs Cn in 30   μ  l PBS. 
Mice were killed when indicated, and their tracheas were cannulated for 
BAL with 3 aliquots of 0.8 ml ice-cold PBS. Serial dilutions of BAL fl  uid 
were plated in triplicate, and CFUs were determined. Lung tissue was re-
moved and digested at 37  °  C in collagenase solution, and single cell suspen-
sions were prepared for FACS analysis. In parallel experiments, lung tissue 
was collected for histological and biochemical analysis. For survival experi-
ments, mice were inoculated by intraperitoneal injection with 5   ×   10  7   CFUs 
NCTC in 0.3 ml PBS, as described above. Lung, liver, and spleen were col-
lected postmortem for histological and biochemical analysis. 
  LPS lung infl  ammation.     Mice were challenged intranasally with 10   μ  g 
LPS (  Escherichia coli   serotype B5:055; Sigma-Aldrich) in PBS. BAL fl  uid was 
collected as described above. Lung tissue was removed and digested at 37  °  C 
in collagenase solution, and single cell suspensions were prepared for FACS 
analysis. In parallel experiments, lung tissue was collected for histological and 
biochemical analysis. 
  Macrophage and PMN isolation and stimulation.     Bone marrow  –  de-
rived macrophages (BMDMs) were generated as described previously (  11  ). 
Peritoneal macrophages were elicited by intraperitoneal injection of 1.5 ml 
of 3% thioglycollate (Difco) or 1% Biogel (Bio-Rad Laboratories). After 3 d, 
cells were harvested and plated in RPMI 1640 supplemented with 10% heat-
inactivated FCS, 100 U/ml penicillin/streptomycin, and 2 mM glutamine. 
Peritoneal PMNs were isolated 4 h after thioglycollate injection and main-
tained in RPMI 1640 supplemented with 10% heat-inactivated autologous 
serum, 100 U/ml penicillin/streptomycin, and 2 mM glutamine. For infec-
tion experiments, bacteria were prepared as described above, macrophages 
were washed with antibiotic-free media, and bacteria were added at a multi-
plicity of infection (MOI) of 5:1. Killing assays were performed as described 
previously (  11, 24  ). In some experiments, macrophages were treated with 
heat-killed bacteria, and bacteria were prepared as described above and heat 
killed for 30 min at 80  °  C. For other experiments, LPS was used at a concen-
tration of 100 ng/ml and recombinant mouse IFN-     was used at 100 U/ml 
(PeproTech). 
IKK     acts to limit infl  ammation by inhibiting the persistent 
expression of NF-    B  –  dependent proinflammatory genes. 
However, IKK    /NF-    B also acts to limit Stat-1 activity and 
the overexpression of Stat-1  –  dependent genes as a result of 
autocrine and paracrine IFN signaling. These antiinfl  amma-
tory roles for the IKK complex have clear implications for 
the clinical use of IKK inhibitors. 
  Here, we have described a new role for IKK     in the 
suppression of M1 macrophage activation during infection 
through the inhibition of Stat1 activity. To further test this 
hypothesis, we infected IKK          Mye   mice with the fungal 
pathogen   Cryptococcus neoformans   (Cn). Cn infects macro-
phages and promotes an M2 phenotype to evade a protective 
Th1 response (  20  ). IKK          Mye   mice infected with Cn showed 
increased clearance of fungi after 10 d compared with control 
mice (Fig. S2 B, available at http://www.jem.org/cgi/
content/full/jem.20080124/DC1; IKK      f/f   vs. IKK          Mye  ; *, 
P = 0.003). FACS analysis of BAL and lung tissue from Cn-
infected mice showed MHC class II expression on alveolar 
macrophages was signifi  cantly increased (Fig. S2 C; IKK      f/f   
vs. IKK          Mye  ; *, P = 0.0172). In addition, the proportion of 
T cells in the lungs of IKK          Mye   mice was elevated, although 
these data did not reach statistical signifi  cance (Fig. S2 C). 
These changes correlated with increased IFN-     in BAL and 
reduced levels of Th2 cytokines IL-4 and IL-5 (Fig. S2 D), 
suggesting a switch to a protective Th1 response. These data, 
and that described above, suggest that IKK     inhibits M1 
macrophage activation during infection with both extracellu-
lar Streptococci and the intracellular fungal pathogen Cn. 
The precise pathophysiological signifi  cance of M1 and M2 
macrophage populations is not yet well established (  6, 7  ). 
However, it is clear that M1 macrophage activation is critical 
to control certain infections, but a switch to an M2 pheno-
type may limit the innate immune response and be required 
for the resolution of infl  ammation. 
  In summary, IKK     plays a tissue-specifi  c role in infl  am-
mation. In resident tissue cells, such as lung epithelium, IKK    -
mediated NF-    B activation drives cytokine and chemokine 
production required to initiate the inflammatory response 
(  9, 13  ). However, NF-    B activation in resident macrophages 
or leukocytes recruited during infl  ammation has an antiinfl  am-
matory role (  3, 21  ). This may represent a mechanism to pre-
vent the over-exuberant activation of macrophages during 
infl  ammation. In a parallel study in this issue on page   1261  , 
Hagemann et al. (  22  ) show that inhibition of IKK     in tu-
mor-associated macrophages, which have an M2 phenotype 
(  8, 23  ), also leads to increased Stat1 activation and a polarized 
M1 phenotype (increased; NOS2, MHC class II, and IL-12). 
However, in this context IKK     inhibition confers enhanced 
tumoricidal activity, analogous to the increased antimicro-
bial activity observed in IKK          Mye   mice. It will be interest-
ing to investigate if pathogens can highjack the IKK      –  NF-    B 
pathway to evade M1 macrophage activation and innate im-
munity in a similar fashion to tumor cells. 
  Considering the dominant role of Stat1 in regulation of 
NOS2, MHC class II, and IL-12 expression, it is likely that JEM VOL. 205, June 9, 2008  1275
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Student  ’  s   t   test or Mann-Whitney test was performed where appropriate to 
test the statistical signifi  cance between datasets and p-values indicated. 
  Online supplemental material.     Fig. S1 shows the increased immuno-
stimulatory activity of IKK            macrophages. Fig. S2 shows that macrophage 
IKK     activity inhibits protective immunity to Cn infection. Figs. S1 and S2 
are available at http://www.jem.org/cgi/content/full/jem.20080124/DC1. 
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